SCHEMBL12366200

SCHEMBL12366200

[C-]#[N+]CC(=O)Nc1ccc(-c2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
NPC1 O15118 1/20 0.62
MITF O75030 1/20 0.62
HTT P42858 1/20 0.62
RAB9A P51151 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
HDAC1 Q13547 4/20 0.54
HDAC2 Q92769 4/20 0.54
HDAC3 O15379 3/20 0.54
HDAC4 P56524 3/20 0.54
HDAC7 Q8WUI4 3/20 0.54
HDAC10 Q969S8 3/20 0.54
HDAC11 Q96DB2 3/20 0.54
HDAC8 Q9BY41 3/20 0.54
HDAC6 Q9UBN7 3/20 0.54
HDAC9 Q9UKV0 3/20 0.54
HDAC5 Q9UQL6 3/20 0.54
SLC1A3 P43003 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366123 0.91 EPHX2 (0.57) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL12366199 0.87 MGLL (0.62) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7568726 0.78 ALDH1A1 (0.70) ALDH1A1NPC1MITFHTTRAB9A
SCHEMBL70039 0.78 ALDH1A1 (0.70) ALDH1A1NPC1MITFHTTRAB9A
SCHEMBL9976374 0.77 EPHX2 (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL12366121 0.77 LMNA (0.64) ALDH1A1SMN1; SMN2MEN1KMT2AHDAC1
SCHEMBL2330263 0.77 ALDH1A1 (1.00) ALDH1A1NPC1MITFHTTRAB9A
SCHEMBL8789408 0.77 ALDH1A1 (0.68) ALDH1A1NPC1MITFHTTRAB9A
SCHEMBL16201474 0.77 KMT2A (0.77) ALDH1A1NPC1MITFHTTRAB9A
SCHEMBL16197808 0.77 ALDH1A1 (0.68) ALDH1A1NPC1MITFHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed